Issue 7/2008
Content (14 Articles)
Local therapy of cancer with free IL-2
Willem Den Otter, John J. L. Jacobs, Jan J. Battermann, Gerrit Jan Hordijk, Zachary Krastev, Ekaterina V. Moiseeva, Rachel J. E. Stewart, Paul G. P. M. Ziekman, Jan Willem Koten
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions
Jennifer K. Mulligan, Deanne M. R. Lathers, M. Rita I. Young
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients
Xiaorong Lin, Nancy H. Gudgeon, Edwin P. Hui, Hui Jia, Xue Qun, Graham S. Taylor, Martin C. N. M. Barnardo, C. Kit Lin, Alan B. Rickinson, Anthony T. C. Chan
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses
Richard Harrop, Noel Drury, William Shingler, Priscilla Chikoti, Irina Redchenko, Miles W. Carroll, Susan M. Kingsman, Stuart Naylor, Richard Griffiths, Neil Steven, Robert E. Hawkins
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200
A. Siva, H. Xin, F. Qin, D. Oltean, K. S. Bowdish, A. Kretz-Rommel
Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease
Tao Gu, Mehmet O. Kilinc, Nejat K. Egilmez
RETRACTED ARTICLE: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF
Nobuto Yamamoto, Hirofumi Suyama, Hiroaki Nakazato, Nobuyuki Yamamoto, Yoshihiko Koga
A33 antigen displays persistent surface expression
Margaret E. Ackerman, Cecile Chalouni, Michael M. Schmidt, Vivek V. Raman, Gerd Ritter, Lloyd J. Old, Ira Mellman, K. Dane Wittrup
Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene
Li-Hua Xie, Fion Wan-Yee Sin, Samuel Chak-Sum Cheng, Ying-Kit Cheung, Kin-Tak Chan, Yi Xie, Yong Xie
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
P. Hersey, G. M. Halliday, M. L. Farrelly, C. DeSilva, M. Lett, S. W. Menzies
Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)2 fragment of anti-CD16 antibody
Anahid Jewett, Antonia Teruel, Marcela Romero, Christian Head, Nicholas Cacalano
In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1
Claudia Gravekamp, Belinda Leal, Ashley Denny, Rumana Bahar, Shellye Lampkin, Francisco Castro, Sun Hee Kim, Dan Moore, Robert Reddick
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
Assefa Wondimu, Tianqian Zhang, Thomas Kieber-Emmons, Phyllis Gimotty, Katrin Sproesser, Rajasekharan Somasundaram, Soldano Ferrone, Chun-Yen Tsao, Dorothee Herlyn
Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression
Ya-Wen Hsiao, Kuang-Wen Liao, Tien-Fu Chung, Chen-Hsuan Liu, Chia-Da Hsu, Rea-Min Chu